The epidemic situation and the mass nature of the lesion force us to differentiate hemorrhagic conjunctivitis from another very common and well-studied disease - acute epidemic adenoviral conjunctivitis.
In the treatment of leprosy damage to the organ of vision, the main thing is to conduct general specific therapy. The total duration of treatment for patients with lepromatous and borderline leprosy is 5-10 years, with tuberculoid and undifferentiated - at least 3-5 years.
Before the widespread use of sulfone drugs, damage to the organ of vision in leprosy occurred in a large percentage of cases: 77.4%. No other infectious disease has seen such a high frequency of eye damage.
The causative agent of human leprosy is Mycobacterium leprae (M. leprae hominis, M. Hanseni), described in 1874 by G. Hansen, and belongs to the genus Mycobacterium.
Leprosy (an outdated name for leprosy) is one of the most severe chronic infectious diseases of humans, manifested by damage to the skin, mucous membranes, peripheral nervous system, visual organ, lymph nodes and internal organs.
Diphtheria is an acute infectious disease characterized by fibrinous inflammation in the area of the infection's entry point. Hence the name of the disease (Greek diphtera - film).
The introduction of fungi into the cavity of the eyeball through penetrating wounds, perforating corneal ulcers or hematogenous routes is fraught with severe intraocular inflammation, often ending in the death of the eye.
Fungal diseases of the cornea, which have become more frequent in recent years and often have a severe course and a poor outcome, are of leading importance in the pathology of the organ of vision caused by fungi.
